Bridging the gap: Advances in artificial liver support
Open Access
- 5 July 2012
- journal article
- supplements
- Published by Wolters Kluwer Health in Liver Transplantation
- Vol. 18 (Supplement) , S10-S14
Abstract
Key Points: 1. The goals of liver support therapy include the following: • To provide detoxification and synthetic function during liver failure. • To remove or reduce the production of proinflammatory cytokines to correct the systemic inflammatory response of liver failure. • To stimulate the regeneration of the injured liver and increase the likelihood of spontaneous recovery. 2. There is a large unmet need for a liver support device because of the shortage of organs for liver transplantation and the risks of major surgery. 3. Liver support devices can be divided into 2 groups: purely mechanical artificial devices and cell-based bioartificial devices. Both provide detoxification, but bioartificial liver devices provide the option of synthetic function and biotransformation activities that are not possible with a purely mechanical device. 4. An abundant high-quality supply of human hepatocytes is not currently available for liver cell therapy. However, such a supply is essential for successful bioartificial liver therapy. Novel options are under development for the unlimited production of high-quality human hepatocytes. Liver Transpl, 2012. © 2012 AASLD.Keywords
This publication has 24 references indexed in Scilit:
- Cell Therapies for Liver DiseasesLiver Transplantation, 2011
- Efficient production of Fah -null heterozygote pigs by chimeric adeno-associated virus-mediated gene knockout and somatic cell nuclear transferHepatology, 2011
- Rat hepatocyte spheroids formed by rocked technique maintain differentiated hepatocyte gene expression and function #Hepatology, 2009
- Acute liver failureHepatology, 2007
- Cells for bioartificial liver devices: The human hepatoma‐derived cell line C3A produces urea but does not detoxify ammoniaBiotechnology and Bioengineering, 2007
- Robust expansion of human hepatocytes in Fah−/−/Rag2−/−/Il2rg−/− miceNature Biotechnology, 2007
- Prometheus Versus Molecular Adsorbents Recirculating System: Comparison of Efficiency in Two Different Liver Detoxification DevicesArtificial Organs, 2006
- In vivo quantification of liver dialysis: Comparison of albumin dialysis and fractionated plasma separationJournal of Hepatology, 2005
- Initial experience with the modified extracorporeal liver-assist device for patients with fulminant hepatic failure: system modifications and clinical impactTransplantation, 2002
- Heterologous Liver Perfusion in Treatment of Hepatic FailureAnnals of Surgery, 1965